Opioid Manufacturer Indivior's Chief Executive Officer

VA 2026 Small Manufacturers

OIG Controlled Substance

Penalty

Outcome

OIG enforcement action against Opioid Manufacturer Indivior's Chief Executive Officer for controlled substance.

Details

Opioid Manufacturer Indivior's Chief Executive Officer — OIG Enforcement (2026)

OIG took enforcement action against Opioid Manufacturer Indivior's Chief Executive Officer in VA in 2026 involving controlled substance violations in the Small Manufacturers sector.

Violation types: Controlled Substance
Entity type: Healthcare Provider
Penalty type: Criminal
Location: VA

Source: Opioid Manufacturer Indivior's Chief Executive Officer Pleads Guilty in Connection with Drug Safety Claims

How Crucible Prevents This

Crucible's controlled substance tracking enforces DEA-compliant inventory reconciliation, flags prescribing pattern anomalies, and requires segregation of duties for dispensing and record-keeping.

Source: Opioid Manufacturer Indivior's Chief Executive Officer Pleads Guilty in Connection with Drug Safety Claims

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works